Long-term oral administration of hyperoside ameliorates AD-related neuropathology and improves cognitive impairment in APP/PS1 transgenic mice
Liang Chen, Yiping Zhou, Huayi Liu, Juan-Hua Gu, Xin‐Fu Zhou, Zeng Yue-Qin
Topics & Concepts
HyperosideNeuroprotectionGenetically modified mouseNeuroinflammationPharmacologyNeuropathologyAlzheimer's diseaseNeuroscienceMedicineOxidative stressTransgeneCognitive declineInflammationBiologyDementiaImmunologyEndocrinologyPathologyQuercetinDiseaseBiochemistryGeneAntioxidantAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsCholinesterase and Neurodegenerative Diseases